Matinas BioPharma Reports First Quarter 2020 Financial Results and Operational Highlights

NEXT STORY
CorMedix Inc. Reports First Quarter 2020 Financial Results and Provides Business Update
PREV STORY
10x Genomics Reports First Quarter 2020 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FDA Grants Orphan Drug Designation (ODD) for Xeris Pharmaceuticals’ Ready-to-Use Glucagon for the Treatment of Hyperinsulinemic Hypoglycemia (HH). Results from Phase 2a Study in Post-Bariatric Hypoglycemia, Associated with HH, Published.

Chicago, IL, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty ...

author_avatar
NASDAQ Market News

Immunocore presents phase 3 data comparing tebentafusp with investigator’s choice in the clinical trial plenary session at the American Association for Cancer Research 2021 Annual Meeting

author_avatar
NASDAQ Market News

Gluco Shield Pro Reviews – Negative Side Effects or Legit Ingredients?

author_avatar
NASDAQ Market News